EP Patent

EP2297115A2 — Quinazoline derivatives

Assigned to Hutchmed Holdings Enterprises Ltd · Expires 2011-03-23 · 15y expired

What this patent protects

Quinazoline derivatives having a benzofuran substituent. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.

USPTO Abstract

Quinazoline derivatives having a benzofuran substituent. It also discloses a method of treating an angiogenesis-related disorder with one of these compounds.

Drugs covered by this patent

Patent Metadata

Patent number: EP2297115A2
Jurisdiction: EP
Classification: —
Expires: 2011-03-23
Drug substance claim: No
Drug product claim: No
Assignee: Hutchmed Holdings Enterprises Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.